Ind-Swift Laboratories Limited (BOM:532305)
India · Delayed Price · Currency is INR 390.85
-9.15 (-2.29%)
At close: Oct 7, 2026
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 34.01 billion as of October 7, 2026. Its market cap has increased by 309.73% in one year.
Market Cap
34.01B
Enterprise Value
29.80B
Revenue
6.74B
Global Rank
n/a
Country Rank
n/a
PE Ratio
59.33
ChartMarket Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 34.01B, an increase of 30,399.03%. That is a compound annual growth rate of 23.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 34.01B | 372.76% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 280.43B |
| Shilpa Medicare | 201.61B |
| Suven Life Sciences | 86.49B |
| Symbiotec Pharmalab | 75.16B |
| IOL Chemicals and Pharmaceuticals | 60.35B |
| Gujarat Themis Biosyn | 48.55B |
| NGL Fine-Chem | 18.07B |
| Bajaj HealthCare | 10.89B |